Unknown

Dataset Information

0

Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.


ABSTRACT: Results from a 2012 high-throughput screen of the NIH Molecular Libraries Small Molecule Repository (MLSMR) against the human muscarinic receptor subtype 1 (M1) for positive allosteric modulators is reported. A content-rich screen utilizing an intracellular calcium mobilization triple-addition protocol allowed for assessment of all three modes of pharmacology at M1, including agonist, positive allosteric modulator, and antagonist activities in a single screening platform. We disclose a dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-one hit (DBPQ, CID 915409) and examine N-benzyl pharmacophore/SAR relationships versus previously reported quinolin-3(5H)-ones and isatins, including ML137. SAR and consideration of recently reported crystal structures, homology modeling, and structure-function relationships using point mutations suggests a shared binding mode orientation at the putative common allosteric binding site directed by the pendant N-benzyl substructure.

SUBMITTER: Han C 

PROVIDER: S-EPMC4278958 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators.

Han Changho C   Chatterjee Arindam A   Noetzel Meredith J MJ   Panarese Joseph D JD   Smith Emery E   Chase Peter P   Hodder Peter P   Niswender Colleen C   Conn P Jeffrey PJ   Lindsley Craig W CW   Stauffer Shaun R SR  

Bioorganic & medicinal chemistry letters 20141118 2


Results from a 2012 high-throughput screen of the NIH Molecular Libraries Small Molecule Repository (MLSMR) against the human muscarinic receptor subtype 1 (M1) for positive allosteric modulators is reported. A content-rich screen utilizing an intracellular calcium mobilization triple-addition protocol allowed for assessment of all three modes of pharmacology at M1, including agonist, positive allosteric modulator, and antagonist activities in a single screening platform. We disclose a dibenzyl-  ...[more]

Similar Datasets

| S-EPMC6010083 | biostudies-literature
| S-EPMC4384557 | biostudies-other
| S-EPMC3435639 | biostudies-literature
| S-EPMC9064357 | biostudies-literature
| S-EPMC4780333 | biostudies-literature
| S-EPMC6393703 | biostudies-literature
| S-EPMC2977731 | biostudies-literature
| S-EPMC3011395 | biostudies-literature
| S-EPMC5972072 | biostudies-literature
| S-EPMC8588486 | biostudies-literature